Mark Litzow

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: Comparative toxicity and outcomes

Daniel J. Weisdorf, Michael R. Bishop, B. Dharan et al. · Biology of Blood and Marrow Transplantation · 2002 · 59 citations · Full text

Medicine, Hematology, Oncology +14

Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis

Ayalew Tefferi, Daniel K. Partain, Jeanne Palmer et al. · American Journal of Hematology · 2018 · 49 citations · Full text

Medicine, Hematology, Immunogenetics +14

Patients With Therapy-Related CMML Have Shorter Median Overall Survival Than Those With De Novo CMML: Mayo Clinic Long-Term Follow-Up Experience

Salih Subari, Mrinal M. Patnaik, Dima Alfakara et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 22 citations

Medicine, Clinical Sciences, Oncology +4

Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent

Liuyan Jiang, Sunny Malik, Mark Litzow et al. · Transfusion · 2011 · 14 citations

Medicine, Cell Biology, Hematology +17

Results of the ECOG E1900 Trial in Younger Adults with AML Using an Event Free Survival Endpoint Are Concordant with Results Based on Overall Survival: Potential for a Surrogate Endpoint to Facilitate Rapid Approval of Therapies in AML

Marlise R. Luskin, Ju‐Whei Lee, Hugo F. Fernández et al. · Blood · 2014 · 12 citations

Medicine, Oncology, Survival Analysis +11